Acurx Pharmaceuticals LLC (ACXP) — Financial Flexibility Index
Acurx Pharmaceuticals LLC (ACXP) has a Financial Flexibility Index of -0.60x as of June 2026. Free cash flow of $-1.71 Million (operating CF $-1.71 Million minus capex $0.00) represents -1% of total liabilities ($2.83 Million). Check Acurx Pharmaceuticals LLC (ACXP) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acurx Pharmaceuticals LLC Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Acurx Pharmaceuticals LLC across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Acurx Pharmaceuticals LLC.
Annual Financial Flexibility Index for Acurx Pharmaceuticals LLC (2019–2025)
Year-by-year free cash flow to debt coverage for Acurx Pharmaceuticals LLC. Explore how well can Acurx Pharmaceuticals LLC service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.80x | $-6.79 Million | $-6.79 Million | $2.42 Million | ▲ +12.4% |
| 2024 | -3.20x | $-10.38 Million | $-10.38 Million | $3.24 Million | ▲ +0.6% |
| 2023 | -3.22x | $-9.80 Million | $-9.80 Million | $3.04 Million | ▲ +11.9% |
| 2022 | -3.66x | $-7.54 Million | $-7.54 Million | $2.06 Million | ▲ +38.4% |
| 2021 | -5.94x | $-5.01 Million | $-5.01 Million | $843.91K | ▲ +7.4% |
| 2020 | -6.42x | $-3.35 Million | $-3.35 Million | $522.43K | ▼ -175.5% |
| 2019 | -2.33x | $-3.99 Million | $-3.99 Million | $1.71 Million | — |